Your shopping cart is currently empty

Jun15716 is an inhibitor of the enterovirus 2C protein (EVs 2C) with Ki values of 15.9 μM for EV-D68, 44.2 μM for EV-A71, and 17.8 μM for CVB3. It exhibits potent antiviral activity against EV-D68 US/MO/14-18947 and CVB3 Nancy cells, with EC50 values of 1.0 μM and 0.7 μM, respectively. Jun15716 is applicable in viral infection research, including studies on meningitis, hand-foot-and-mouth disease (HFMD), and viral myocarditis.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | Jun15716 is an inhibitor of the enterovirus 2C protein (EVs 2C) with Ki values of 15.9 μM for EV-D68, 44.2 μM for EV-A71, and 17.8 μM for CVB3. It exhibits potent antiviral activity against EV-D68 US/MO/14-18947 and CVB3 Nancy cells, with EC50 values of 1.0 μM and 0.7 μM, respectively. Jun15716 is applicable in viral infection research, including studies on meningitis, hand-foot-and-mouth disease (HFMD), and viral myocarditis. |
| Molecular Weight | 304.47 |
| Formula | C19H32N2O |
| Cas No. | 827034-42-4 |
| Smiles | O=C(NCCN(C)C)C=1C=C(C=C(C1)C(C)(C)C)C(C)(C)C |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.